TG Therapeutics Inc. (TGTX) declined -5.55% or -0.3 to $5.11. It is near to 704262 shares traded, which is 44.82% compare to the average total volume 1.57 million. The market cap of TGTX is $423.20 million. The year to date change is -43.72%. The 52 week price range is from $4.2 to $17.35. Price of TGTX have changed 9.74% during last week. It have changed 2.66% over last month, -55.47% over last 3 months, -59.78% over last 6 months and -28.34% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TGTX is 7.30. It is 42.86% above current price. The 200-day Moving Averages for TGTX is 11.86. It is 132.09% above current price. The 52-week High is 17.35. It is 239.53% from the current price. The 52-week Low is 4.2. It is -17.81% from current price.
There are some statistics of TGTX. It is has market cap $423.20 million. The share outstanding is 82.82 million. The average volume is 1.57 million. The revenue is 38096. The percent of top 15 Institution holding is 26.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TGTX is -163.50%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TGTX is -121.26%.